Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Geriatric Assessment and Intervention for Older Patients With Frailty in the Emergency Department (GAOPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03751319
Recruitment Status : Completed
First Posted : November 23, 2018
Last Update Posted : August 11, 2021
Sponsor:
Collaborators:
City of Espoo
University of Helsinki
Information provided by (Responsible Party):
Janne Alakare, Helsinki University Central Hospital

Brief Summary:

Comprehensive Geriatric Assessment (CGA) is an established approach for better detection of frailty-related problems and includes individualized treatment plan with multi-discipline supportive and treating measures for the older frailty patients. However, there is limited evidence of feasibility and efficacy of the CGA when provided in the emergency department setting.

In the GAOPS-study the efficacy of the CGA in emergency department setting will be studied by randomized controlled study protocol. We aim to study if the CGA provided in the ED is feasible, safe and efficient method when added with standard emergency care for older frail patients.


Condition or disease Intervention/treatment Phase
Frail Elderly Syndrome Patient Admission Hospital Readmission Length of Stay Fall Quality of Life Other: CGA Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 432 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Randomized Controlled Trial
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Geriatric Assessment and Intervention for Older Patients With Frailty in the Emergency Department. Randomized Controlled Trial
Actual Study Start Date : December 11, 2018
Actual Primary Completion Date : June 7, 2020
Actual Study Completion Date : July 2, 2021

Arm Intervention/treatment
Active Comparator: Standard Emergency Care + CGA
Standard Care is provided for the acute condition as usual by the ED personnel. Besides the standard care provided by ED personnel, patients are systemically screened and assessed by physician trained for geriatrics or geriatric emergency medicine. Geriatric multi-discipline treatment plan and recommendations are given if suitable for the case.
Other: CGA
Comprehensive Geriatric Assessment

No Intervention: Standard Emergency Care
Standard Care is provided for the acute condition as usual by the ED personnel.



Primary Outcome Measures :
  1. Cumulated Length of Stay [ Time Frame: Day 365 ]
    Cumulated stay (days) in hospital wards (university hospital and community hospital) including all admissions during the follow-up.


Secondary Outcome Measures :
  1. Admissions [ Time Frame: Day 30, Day 365 ]
    Number of admissions to the hospital wards (university hospital and community hospital) during the follow-up.

  2. Admission rate [ Time Frame: Day 0 ]
    Proportion of admitted patients (university hospital or community hospital ward) from the index ED-visits.

  3. Readmissions in the ED [ Time Frame: Hour 72, Day 30, Day 365 ]
    Re-visits to the ED after the index-visit.

  4. Living at home [ Time Frame: Day 365 ]
    Proportion of the patients living at home.

  5. Quality of Life [ Time Frame: Day 0, Day 365 ]
    Change of the quality of life during one year follow-up using the standardized questionnaire EuroQol EQ-5D-5L. Measured value is the index value defined by the EuroQol group.


Other Outcome Measures:
  1. Length-of-Stay in the ED [ Time Frame: Day 0 ]
    Length-of-Stay (h) of the index-visit in the ED

  2. Length-of-Stay in the ward [ Time Frame: Day 365 ]
    Length-of-Stay (d) in the hospital ward of admitted patients from the index-visit in the ED

  3. Mortality [ Time Frame: Day 365 ]
    Mortality during the one-year follow-up.

  4. Falls [ Time Frame: Day 365 ]
    Number of falls which result in new ED visit during the one-year follow-up



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age of minimum 75 years
  • "Clinical Frailty Scale" minimum 4 estimated at the arrival to the ED by nurse

Exclusion Criteria:

  • Non-resident of the counties (City of Espoo, Kirkkonummi, Kauniainen) of the hospital district.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03751319


Locations
Layout table for location information
Finland
Helsinki University Hospital, Jorvi ED
Espoo, Uusimaa, Finland, 02740
Sponsors and Collaborators
Helsinki University Central Hospital
City of Espoo
University of Helsinki
Investigators
Layout table for investigator information
Study Director: Veli-Pekka Harjola Department of Emergency Medicine and Services, Helsinki University Hospital
Principal Investigator: Janne Alakare, MD Department of Emergency Medicine and Services, Helsinki University Hospital
Additional Information:
Publications of Results:
Layout table for additonal information
Responsible Party: Janne Alakare, Senior physician in Emergency Medicine, Helsinki University Central Hospital
ClinicalTrials.gov Identifier: NCT03751319    
Other Study ID Numbers: TYH2018304
HUS1171/2018 ( Other Identifier: Helsinki University Hospital )
First Posted: November 23, 2018    Key Record Dates
Last Update Posted: August 11, 2021
Last Verified: August 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Frailty
Disease Attributes
Pathologic Processes